Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice Regarding the Status of Share Repurchases
Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation
Partial Correction to the Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
Notice Regarding Change in Major Shareholders
Notification of Completion of Share Repurchase Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
Notice Regarding Share Repurchase Through Off-Auction Own Share Repurchase Trading System (ToSTNeT-3)
Notice Regarding Share Repurchase and Cancellation of Treasury Stock
Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
(Delayed)Notice Regarding the Difference of Nonconsolidated Financial Results as Compared to Actual Results for the Previous Year
Approach and Policy on Reduction of Investment Units
Consolidated Financial Results for the Fiscal Year Ended December 31, 2024 [IFRS]
Otsuka, 20% Decrease in Net Income for The Current Fiscal Year
Otsuka, Last Fiscal Year Net Income Revised Upward by 43%, Exceeded Record Profit Forecast
Notice Regarding Revisions of Consolidated Results Forecast for FY2024
Otsuka Announces FDA Plans to Host an Advisory Committee Meeting to Discuss the sNDA for Brexpiprazole for the Treatment of Adults with PTSD
Notification of Completion of Share Repurchase and Number of Treasury Stock to be Cancelled
Otsuka Pharmaceutical Factory, Inc. and ICU Medical Announce the Establishment of Joint Venture
Notice Regarding the Status of Share Repurchases
Otsuka Holdings Co., Ltd., January-September (Third Quarter Cumulative) Net Income Increases by 19%